Inspire Medical Systems Inc (INSP)
Cash ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 150,150 | 185,537 | 441,592 | 214,467 | 190,518 |
| Short-term investments | US$ in thousands | 295,396 | 274,838 | 9,821 | 0 | 43,844 |
| Total current liabilities | US$ in thousands | 88,501 | 78,105 | 61,186 | 41,307 | 20,725 |
| Cash ratio | 5.03 | 5.89 | 7.38 | 5.19 | 11.31 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($150,150K
+ $295,396K)
÷ $88,501K
= 5.03
The cash ratio for Inspire Medical Systems Inc has shown a diminishing trend over the years, starting at 11.31 on December 31, 2020, and decreasing to 5.03 on December 31, 2024. This trend indicates a reduction in the company's ability to cover its short-term liabilities solely with its cash and cash equivalents. While the cash ratio remains above 1, suggesting the company still has enough liquid assets to cover its short-term obligations, the decreasing values over the years may require closer monitoring to ensure the company maintains its liquidity position in the future.
Peer comparison
Dec 31, 2024